Pulmonary Disease Doctors in Puyallup, WA Accepting Medicare

6 Pulmonary Disease doctors found. Showing 1 - 6

Rizwana Khan, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1450 5th St Se Ste 3600, Puyallup, WA 98372 Phone: 253-841-4378

Nicole D Collett, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1450 5th St Se Ste 3600, Puyallup, WA 98372 Phone: 253-841-4378

Gita Patel, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 702 23rd Ave Se, Puyallup, WA 98372 Phone: 253-841-4378    Fax: 253-841-5881

Robert Jay Frank, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1701 3rd St Se Ste 300, Puyallup, WA 98372 Phone: 253-697-5767

Vernon Nessan, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 702 23rd Ave Se, Puyallup, WA 98372 Phone: 253-841-4378    Fax: 253-841-5881

Collin Burke, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-4000

News Archive

Bioengineering heart parts

Some day, heart attack survivors might have a patch of laboratory-grown muscle placed in their heart, to replace areas that died during their attack.

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Adamas Pharmaceuticals, Inc. presented positive results today from the Phase 2/3 EASED clinical trial of ADS-5102 at the World Parkinson's Congress. ADS-5102 is Adamas' proprietary long-acting capsule formulation of amantadine HCl in development for the treatment of levodopa-induced dyskinesia in Parkinson's disease patients.

Gold particles and infrared light for controlled drug delivery

Using tiny gold particles and infrared light, MIT researchers have developed a drug-delivery system that allows multiple drugs to be released in a controlled fashion.

GENALICE's Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

Today, GENALICE is setting a new standard for ultra-fast and highly reliable detection of all DNA changes in large patient cohorts. In a one-hour online event, the complete genomes of 800 Alzheimer Disease (AD) patients were processed, and by ingeniously using the aggregate information from the complete group, detection of DNA changes, or variants, in individual patients was enhanced.

Read more Medical News

› Verified 9 days ago